Athira Pharma, Inc. ATHA
6.75 USD 0.00 (+0.00%)
At closeJan 9, 2026, 4:00 PM EST
6.95 +0.20 +2.96%
After hours · Jan 9, 4:00 PM ET
6.61 Day range 7.35
52-week range unavailable
- YTD
- -10.83%
- 1 year
- +112.26%
Analyst view
Price target (mean) 0.55 -91.9% downside
Now 6.75
- Target (low)
- 0.50
- Target (mean)
- 0.55
- Target (high)
- 0.60
Ratings (0m) 4 0 buy · 4 hold · 0 sell
- Strong buy0
- Buy0
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 19, 2024 | Mizuho | Downgrade | Outperform | Neutral |
| Sep 4, 2024 | JMP Securities | Downgrade | Market Outperform | Market Perform |
| Sep 4, 2024 | BTIG | Downgrade | Buy | Neutral |
| Aug 19, 2024 | Rodman & Renshaw | Initiated | — | Buy |
| Jun 20, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| May 16, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Aug 11, 2023 | JMP Securities | Maintained | Outperform | Outperform |
| May 15, 2023 | Mizuho | Maintained | Buy | Buy |
| Mar 30, 2023 | BTIG | Maintained | — | Buy |
| Mar 24, 2023 | JMP Securities | Reiterated | — | Market Outperform |
| Jul 7, 2022 | Mizuho | Initiated | — | Buy |
| Jun 23, 2022 | Stifel | Downgrade | Buy | Hold |
| Jun 23, 2022 | JMP Securities | Downgrade | Market Outperform | Market Perform |
| Jun 23, 2022 | Jefferies | Downgrade | Buy | Hold |
| May 10, 2022 | BTIG | Initiated | — | Buy |
| Apr 21, 2022 | Berenberg | Initiated | — | Buy |
| Dec 15, 2021 | Goldman Sachs | Initiated | — | Neutral |
| Oct 13, 2020 | Jefferies | Initiated | — | Buy |
| Oct 13, 2020 | JMP Securities | Initiated | — | Market Outperform |
| Oct 13, 2020 | Stifel | Initiated | — | Buy |
| Oct 13, 2020 | Goldman Sachs | Initiated | — | Buy |